← Back to Library GLP-1 & Metabolic

Semaglutide (Ozempic/Wegovy)

Overview

GLP-1 agonist approved for type 2 diabetes and weight management. Educational information.

Evidence

SUSTAIN and STEP trials show significant weight loss and cardiovascular benefits.

Risks & Considerations

GI side effects, pancreatitis, thyroid concerns. Prescription medication — speak to your doctor.

Approximate Costs

NHS prescription or private £150–350/month.

Ask VAIA AI about Semaglutide (Ozempic/Wegovy) →

⚕ Educational information only. VAIA does not provide medical advice, diagnosis or treatment. Always speak to a qualified healthcare professional before making health decisions.